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Cell volume regulation is a primitive response to
alterations in environmental osmolarity. The NLRP3
inflammasome is a multiprotein complex that senses
pathogen- and danger-associated signals. Here,
we report that, from fish to mammals, the basic
mechanisms of cell swelling and regulatory volume
decrease (RVD) are sensed via the NLRP3 inflamma-
some. We found that a decrease in extracellular
osmolarity induced a K+-dependent conformational
change of the preassembled NLRP3-inactive inflam-
masome during cell swelling, followed by activation
of the NLRP3 inflammasome and caspase-1, which
was controlled by transient receptor potential chan-
nels during RVD. Both mechanisms were necessary
for interleukin-1b processing. Increased extracellular
osmolarity prevented caspase-1 activation by dif-
ferent known NLRP3 activators. Collectively, our
data identify cell volume regulation as a basic con-
served homeostatic mechanism associated with the
formation of the NLRP3 inflammasome and reveal
a mechanism for NLRP3 inflammasome activation.
INTRODUCTION
Changes in cell volume have been adapted to function as
specific signals for the regulation of important physiological
processes (Hoffmann et al., 2009; Lang et al., 1998). In many
physiological conditions, cells exhibit rapid volume-regulatory
mechanisms to recover their functionality in response to different
signals, and alterations in osmosensing or osmosignaling are
associated with a variety of pathophysiological conditions
(Lang et al., 1998). Cell swelling has been reported to occur
during different clinical situations such as hypoxia, ischemia,
hyponatremia, hypothermia, and in intracellular acidosis and
diabetic ketoacidosis (Hoffmann et al., 2009; Newman and
Grana, 1988). Cell volume regulation is of prime importance
to the CNS because of the restricted volume of the skull,Imand current clinical treatment of stroke aims to reduce intracra-
nial pressure by administration of hypertonic solutions (Jain,
2008).
Interleukin-1b (IL-1b) influences the pathogenesis and course
of brain diseases, such as epilepsy, or brain injuries, such as
stroke (Li et al., 2011; Rothwell, 2003). IL-1b release is tightly
regulated by the inflammasome, a multiprotein complex that
activates caspase-1, the enzyme responsible for generating
the mature bioactive form of IL-1b (Schroder and Tschopp,
2010). NLRP3 (nucleotide-binding domain and leucine-rich
repeat pyrin 3 domain) oligomerizes and assembles with ASC
(apoptosis-associated speck-like protein containing a caspase
recruitment domain) to form functional inflammasomes in
response to a wide range of extracellular danger signals,
including ATP or crystals. The NLRP3 inflammasome is posi-
tively regulated by low intracellular K+, by increased reactive
oxygen species, and by lysosome membrane disruption
(Hornung et al., 2008; Schroder and Tschopp, 2010; Zhou
et al., 2010), all of which are processes affected during cell
swelling (Hoffmann et al., 2009). Inflammasomes not only regu-
late immune cells, but are also functional in other cell types,
such as neurons, keratinocytes, or pancreatic b cells, and
generate an integrated host effector response (de Rivero Vaccari
et al., 2008; Feldmeyer et al., 2007; Zhou et al., 2010).
An anisosmotic condition represents an important and con-
served danger signal, which, in the case of hypotonicity,
induces processing and release of IL-1b (Perregaux et al.,
1996). Recently, it has been reported that activation of the
NLRP3 inflammasomme by uric acid (monosodium urate,
MSU) crystal is associated with water influx that leads to cell
swelling (Schorn et al., 2011). We found that low osmolarities
induced macrophage swelling and a decrease in intracellular
K+ and Cl concentrations, which activated a regulatory volume
decrease (RVD) process controlled by a transient receptor
potential (TRP) channel with a pharmacology profile close to
TRP melastatin 7 (TRPM7). During RVD, TRP vanilloid 2
(TRPV2) was translocated to the plasma membrane, where
it induced membrane permeabilization. Then, TRP channels
modulated intracellular Ca2+ rise that was necessary for
transforming growth factor b-activated kinase 1 (TAK1) activa-
tion. This mechanism showed that low intracellular K+ is
required but not sufficient to induce activation of the NLRP3munity 37, 487–500, September 21, 2012 ª2012 Elsevier Inc. 487
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Figure 1. Hypotonic Solutions Are Considered Danger Signals
In Vivo
(A) Time-lapse images of THP-1 cells in a hypotonic solution (90 mOsm), initial
volume (white dotted line) and maximum volume (black dotted line) are
indicated; scale bar represents 5 mm.
(B) Relative cell area of THP-1 cells in isotonic (continuous trace) or hypotonic
(dotted trace) solution. n = 50 cells per condition; representative of four
independent experiments. a.u., arbitrary units.
(C) Representative flow-cytometry forward scatter (FSC-H) plots of mouse
F4/80 positive cells in the peritoneum of mice injected for 4 days with an iso-
or hypotonic solution.
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currently used hypertonic fluid therapy and shows that modula-
tion of interstitial osmolarity and TRP inhibition could be benefi-
cial for controlling inflammatory diseases involving the NLRP3
inflammasome.
RESULTS
Macrophage Swelling Activates Caspase-1 and IL-1b
Release via the NLRP3 Inflammasome
We examined cell volume regulation of macrophages after expo-
sure to changes in extracellular osmolarity. Human THP-1
macrophages responded to a reduction in extracellular osmo-
larity with cell swelling followed by an RVD process to recover
their original cellular size (Figures 1A and 1B). Conversely, an
increase in extracellular osmolarity induced macrophage
shrinking followed by a regulatory-volume-increase response
(Figure S1A available online). We made similar observations
among different types of mononuclear and other nonimmune
cells (Figures S1A–S1C). Recurrent sterile intraperitoneal (i.p)
administration of hypotonic solution in mice induced macro-
phage swelling in vivo (Figures 1C–1E) and was sufficient
to significantly increase the number of macrophages in the
peritoneum compared with isotonic-solution-injected animals
(Figure 1F).
After in vitro lipopolysaccharide (LPS) priming, a wide range
of primary and immortalized human and murine macrophages
responded to reduced extracellular osmolarity by releasing
caspase-1-dependent cytokines IL-18 and IL-1b (Figures 2A,
2B, and S2A). Such release was not observed when cells were
exposed to hypertonic solutions or for tumor necrosis factor-
a (TNF-a), a caspase-1-independent cytokine (Figure 2A). The
release of IL-1b was abolished with a specific caspase-1 inhib-
itor (Figure 2C). Active caspase-1 appeared in discrete isolated
structures (Figure 2D), suggesting the presence of functional
inflammasome-like particles. Contrary to the findings with
classical caspase-1 activators (ATP, nigericin, MSU crystals, or
aluminum [Alu]), a hypotonic solution was able to activate
caspase-1 in both mammalian and teleost fish (Sparus aurata)
macrophages (Figure 2E), both of which are sensitive to the
NLRP3 blocker Bay11-7085 (Juliana et al., 2010) (Figures S2B
and S2C).
In macrophages derived from mice deficient in caspase-1,
ASC, or NLRP3, IL-1b release following hypotonicity was
abolished (Figures 2F, S2D, and S2E) without affecting the
RVD response (Figure S2F). In HEK293 cells, expression of
NLRP3 inflammasome components demonstrated a require-
ment for ASC and the pyrin and NACHT domains of NLRP3 to
activate caspase-1 in response to hypotonic stimulation, as
well as to the K+ ionophore nigericin, a classical NLRP3 activator
(Figures 2G and S2G).(D and E) Percentage of high-FSC-H (D) and mean-FCS-H (E) gated F4/80
positive peritoneal cells, as shown in (C). n = 3 animals per condition.
(F) Percentage of F4/80 positive cells in the peritoneum of mice injected for
4 days with an iso- (n = 6 animals, white circles) or hypotonic (n = 9 animals,
black circles) solution.
Data are presented as mean ± SEM. **p < 0.005; *p < 0.05. See also Figure S1.
Figure 2. Macrophage Swelling Induces
Release of IL-1b and Activation of Cas-
pase-1 via the NLRP3 Inflammasome
(A) ELISA of released IL-1b (blue trace), IL-18 (red
trace), or TNF-a (black trace) and western blot
analysis of mature IL-1b released by THP-1 cells,
primed or not with LPS (1 mg/ml, 4 hr), and
subsequently subjected to different extracellular
osmolarities for 1 hr; ns, no significant difference
compared with isotonic conditions. n = 3 inde-
pendent experiments. Maximum concentrations
of IL-1b, IL-18, and TNF-awere 12.5 ± 0.58, 1.94 ±
0.11, and 1.49 ± 0.19 ng/ml, respectively.
(B) ELISA of IL-1b release by different macro-
phages (Mfs) treated as described in (A). Human
macrophages were: THP-1 cells, primary perito-
neal macrophages (Per) and peripheral blood
monocytes (HPBM); and mouse macrophages
were: primary peritoneal macrophages (Per) and
BMDM. n = 3–7 independent experiments.
(C) Western blot analysis of the cleavage of pro-IL-
1b to its active p17 form (IL-1b) and of caspase-1
to its active p10 subunit by THP-1 cells treated as
described in (A), in the presence or absence of the
caspase-1 inhibitor (Ac-YVAD-AOM, 100 mM). C,
cell lysates; SN, supernatants.
(D) Representative high-resolution, deconvolved
images of mouse peritoneal macrophages treated
as described in (A), stained with fluorescent probe
for active caspase-1 (FLICA, green), and F-actin
cytoskeleton stained with Texas red-phalloidin
(red). Scale bar represents 2.5 mm. The inserts
show staining of a population of >15 cells.
(E) Caspase-1 activity measured in fish macro-
phages (gray bars) or mouse BMDM (white bars)
after hypotonicmedia stimulation (Hypo, 1 hr), ATP
(5mM, 30min), nigericin (1 mM, 30minmammalian
and 1 hr fish), MSU crystals (500 mg/ml, 1 hr), or
Alu crystals (500 mg/ml mammalian and 40 mg/ml
fish, 1 hr). n = 3–4 independent experiments.
(F) ELISA of IL-1b release by bone marrow-derived wild-type (WT), caspase-1-deficient (Casp1/), ASC-deficient (Pycard/), or NLRP3-deficient (Nlrp3/)
macrophages treated as described in (A) or with 3 mM ATP for 30 min; n = 3 independent cultures.
(G) Western blot analysis of the cleavage of pro-caspase-1 to its active p10 subunit in HEK293 cells transfected with pro-caspase-1 and NLRP3; pro-caspase-1,
NLRP3, and ASC; or pro-caspase-1, NLRP3-PYR deletion, and ASC, incubated for 1 hr with hypotonic solution or 30 min with nigericin (5 mM).
Data are presented as mean ± SEM. **p < 0.001. See also Figure S2.
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To examine real-time intermolecular interactions between
NLRP3 proteins during cell swelling, we labeled the terminus
(C terminus: Ct; N terminus: Nt) of these proteins with yellow
fluorescent protein (YFP) or Renilla-luciferase (Luc) to record
bioluminescence resonance energy transfer (BRET) (Figure 3A).
We first demonstrated that our NLRP3-YFP- and NLRP3-Luc-
tagged proteins were still functional and were able to activate
caspase-1 (Figure S3A). Using our validated model of swelling-
induced inflammasome activation in HEK293 cells (Figures 2G
and S1C), we found that prior to stimulation, NLRP3 proteins
were in spatial proximity to each other, as a specific saturated
BRET signal was found between them (Figure 3B). As a control,
the noninteracting protein b-arrestin-YFP yielded a nonspecific
linear increase of the BRET signal with NLRP3-Luc-Ct (Fig-
ure 3B). The BRET signal was higher between NLRP3-Luc-Ct
and NLRP3-YFP-Nt than between NLRP3-Luc-Ct and NLRP3-ImYFP-Ct (Figure 3B), suggesting that in resting NLRP3 com-
plexes, the pyrin-Nt of one NLRP3 protein is in closer proximity
to the Ct of adjacent NLRP3 (see the proposed model in Fig-
ure 3J). Given that NLRP3 oligomerization is thought to occur
through interaction between central NACHT domains (Schroder
and Tschopp, 2010) and deletion of NACHT impairs caspase-1
activation after hypotonic stimulation (Figure S2G), BRET exper-
iments were next performed with NLRP3 constructs deleted
for this domain (NLRP3-DNACHT). When coexpressed with
NLRP3-Luc-Ct, NLRP3-DNACHT-YFP-Ct yielded a nonspecific
linear increase of the BRET signal (Figure S3B), confirming the
role of NACHT domains in NLRP3 proteins’ interaction and the
specificity of the BRET signal among full-length NLRP3 mole-
cules. Coexpression of ASC with NLRP3 induced an increase
of the BRET signal between NLRP3 complexes (Figure 3C).
NLRP3 protein interaction was further characterized with bio-
chemical experiments. NLRP3-YFP and NLRP3-Flag proteins
coimmunoprecipitated (coIP) under both resting conditionsmunity 37, 487–500, September 21, 2012 ª2012 Elsevier Inc. 489
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Figure 3. NLRP3 Proteins Form an Inactive Preassembled Complex in Resting Cells
(A) Schematic representation showing NLRP3 BRET donor and acceptor partners.
(B) BRET saturation curves for HEK293 cells transfected with a constant concentration of NLRP3-Luc-Ct and increasing amounts of the BRET acceptor
NLRP3-YFP-Nt (black circles), NLRP3-YFP-Ct (open circles), or b-arrestin-YFP (gray triangles). mBU, milliBRET units.
(C) BRET signal from HEK293 cells transfected with NLRP3-Luc-Ct and NLRP3-YFP-Ct in the presence or absence of ASC coexpression; **p < 0.001.
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showing that NLRP3 protein interactions were not affected by
the stimulation. NLRP3 oligomerization was highly reduced
when the NACHT domain of NLRP3 was deleted (Figure S3C).
During the first 5 min after hypotonic stimulation, the magni-
tude of the BRET signal between NLRP3 proteins was reduced
(Figure 3E). This reduction was more pronounced between
NLRP3-Luc-Ct and NLRP3-YFP-Nt (Figure 3E) and was absent
if cells were maintained in isotonic conditions (Figure S3D). In
control samples, we observed no change in the BRET signal after
hypotonic stimulation using a Luc-YFP fusion construct (Fig-
ure S3E). The decrease in BRET signal observed for NLRP3
proteins during hypotonic shock was also found after nigericin
treatment (Figure S3F) and was due to a conformational change
in the proteins rather than a dissociation of NLRP3-NLRP3
complexes, because we found similar coIP among NLRP3
proteins before and after hypotonic stimulation (see Figure 3D).
Conformational changes in NLRP3 proteins were further
confirmed by studying the Flag-tagged immunoprecipitation
(Flag IP) efficiency of NLRP3-Flag-Nt proteins. Indeed, fewer
proteins were pulled down after a hypotonic stimulation (Figures
3F and 3G), without any degradation or release of NLRP3
proteins (Figures S3G and S3H). The NLRP3 IP efficiency was
restored when either NLRP3 proteins were denatured before
being pulled down (Figures 3F and3G) or when high K+ concen-
trations were used during the IP (Figure 3H). As a control, puri-
nergic receptor P2X, ligand-gated ion channel, 7 (P2X7)-Flag
IP was not affected by the different K+ concentrations (Fig-
ure 3H). This suggests a K+-dependent conformational change
of NLRP3 after hypotonic stimulation, which could alter the
accessibility of the antibody to the Flag epitope. The reduced
IP efficiency was more prominent with ASC coexpression
(Figure 3G), supporting the idea that ASC is able to compact
the Nt of the NLRP3 inflammasome by interacting with its pyrin
domain. Despite the evidence of ASC interaction with inactive
NLRP3 complexes (Figures 3C and 3G), direct protein interac-
tion between NLRP3 and ASC was only evident in coIP experi-
ments after 40 min in hypotonic solution (Figure 3I).
Potassium Depletion Is Not Sufficient to Activate
the NLRP3 Inflammasome
We first found that activation of caspase-1 induced by hypoto-
nicity was dependent on intracellular K+ efflux (Figures 4A–4C),
as this is an established and obligatory step for activating the
NLRP3 inflammasome (Schroder andTschopp, 2010). It is known
that cell swelling activatesCl efflux in conjunctionwith K+ loss to
initiate cellular water efflux and maintain cellular homeostasis
via RVD (Hoffmann et al., 2009). As expected, macrophage intra-(D) NLRP3-YFP and NLRP3-Flag coIP in resting conditions or after hypotonic st
three independent experiments.
(E) Kinetics of net BRET signal in HEK293 cells transfected with the BRET donor NL
(open circles) in response to hypotonic solution.
(F–H) NLRP3-Flag or P2X7-Flag IP after hypotonic stimulation in HEK293. IPwas p
presence of different concentrations of K+ (H). Histograms in (G) are the densit
of three independent blots in the absence or the presence of ASC cotransfection
(I) Kinetics of coIP between ASC and NLRP3-Flag in HEK293 cells after hypoton
three independent experiments.
(J) Proposed model for the intermolecular dynamics of NLRP3 inflammasome ac
Data are presented as mean ± SEM. See also Figure S3.
Imcellular K+ concentration decreased during the first 10 min of cell
swelling (Figure 4A). Blocking intracellular K+ depletion by using
a hypotonic solution with a high concentration of K+ and glycerol
(a membrane-permeable molecule that maintains hypotonicity)
still induced cell swelling but abolished the RVD response and
the release of mature IL-1b (Figures 4B and 4C), suggesting
that in addition to K+ efflux, RVD could be an important process
in activating the inflammasome. To further investigate the role
of RVD in the activation of the inflammasome, we studied the
decrease of intracellular Cl as a controlling step for the RVD
(Figures 4D and 4E). Using NPPB, a general blocker of
swelling-activated Cl channels, we found that preventing the
RVD response also inhibited the release of mature IL-1b (Figures
4E and 4F). Interestingly, NPPB did not alter the depletion of
intracellular K+ mediated by cell swelling (Figure 4G). Thus, intra-
cellular K+ depletion per se is necessary but not sufficient to
induce swelling-evoked processing and release of IL-1b.
TRP Channels Regulate Caspase-1 Activation
We found that in response to hypotonic stimulation, macro-
phages became permeable for large fluorescent molecular
tracer (Figures 5A and S4A). This dye uptake occurred during
RVD (after 10 min of stimulation) and was not dependent on
pannexin-1, P2X7 receptor, or caspase-1 activation (Figures
S4B and S4C). We were able to rule out the possible actions
of ATP released during cell permeabilization activating the
NLRP3 inflammasome, because neither macrophages deficient
in P2X7 receptors nor treatment with apyrase (an enzyme that
degrades ATP) affected IL-1b release in response to hypotonicity
(Figures S4D and S4E). Treatment with the cathepsin B inhibitor
Ca-047-Me did not impair caspase-1 activation or IL-1b release
in response to hypotonicity; therefore, we also ruled out the
involvement of cathepsin B in inflammasome activation (Figures
S4G–S4I); however, hypotonicity was able to induce lysosome
destabilization, as measured by cathepsin release (Figure S4F).
Hypotonicity-induced dye uptake was sensitive to broad TRP
channel blockers (Figure 5A), and TRP inhibition strongly sup-
pressed hypotonicity-induced caspase-1 activation and IL-1b
release without affecting K+ efflux in both mammalian and fish
macrophages (Figures 5B, 5C, S4J, and S4K). We analyzed
the expression of TRP channels in macrophages and found
expression of eight different subunits, TRPV2 and TRPM7
being the ones most expressed (Figure 5D). TRPV2 has been
previously identified as an osmosensor, and TRPM7 has
been involved in controlling the RVD process (Liedtke, 2006;
Muraki et al., 2003; Numata et al., 2007). Blocking TRPM7
function by using high extracellular Mg2+ concentration (Penner
and Fleig, 2007) delayed macrophage RVD, decreased cellimulation in HEK293 cells (C: cell lysates). Western blots are representative of
RP3-Luc-Ct and the acceptor NLRP3-YFP-Nt (black circles) or NLRP3-YFP-Ct
erformed on naive or denatured (SDS + dithiothreitol [DTT]) lysates (F) and in the
ometry quantification of the NLRP3-Flag IP signal after hypotonic stimulation
.
ic stimulation; C, total cell lysates. Western blots are representative of two to
tivation in response to hypotonicity.
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Figure 4. RVD Controls Activation of the
NLRP3 Inflammasome
(A) Relative intracellular K+ concentration of THP-1
cells primed with LPS (1 mg/ml, 4 hr) and subse-
quently subjected to 300 or 90 mOsm extracellular
solution for 1 hr; n = 3 independent experiments.
(B) Relative cell area of THP-1 cells in isotonic
solution (continuous trace) or in hypotonic solu-
tions composed of 120 mM glycerol (dotted trace)
and either 140 mM of NaCl (open squares) or
140 mM of KCl (black circles). n = 50 cells per
treatment; representative of three independent
experiments. a.u., arbitrary units.
(C) Western blot analysis of b-actin and of the
cleavage of pro-IL-1b to its active p17 form (IL-1b)
by LPS-primed THP-1 cells incubated for 1 hr
with a 90 mOsm hypotonic solution (Hypos.) or in
hypotonic solutions composed of 120mMglycerol
and either 140 mM NaCl (Na+ Gly) or 140 mM of
KCl (K+ Gly). C, cell lysates; SN, supernatants.
(D) Relative intracellular Cl concentration of
THP-1 cells treated as in (A); n = 3 independent
experiments.
(E) Relative cell area of THP-1 cells in isotonic
solution (continuous trace) or in 90 mOsm solution
(dotted line) in the absence (open squares) or
presence (closed circles) of 100 mM NPPB. n = 50
cells per treatment; representative of three inde-
pendent experiments. a.u., arbitrary units.
(F) Western blot analysis of the cleavage of pro-IL-
1b to its active p17 form (IL-1b) on THP-1 cells
treated as in (A) in the presence or absence of
NPPB (100 mM).
(G) Relative intracellular K+ concentration of THP-1
cells treated as in (A) in the presence or absence of
NPPB (100 mM).
Western blots are representative of two to three
independent experiments. Data are presented as
mean ± SEM. **p < 0.001.
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5G). Similar results were obtained using the broad TRP channel
blockers lanthanum, ruthenium red, and 2-APB (Figures 5A, 5C,
S4J, and S4O). Alternatively, it is known that the absence of ex-
tracellular Mg2+ potentiates TRPM7 function (Penner and Fleig,
2007), and we found that in macrophages exposed to hypotonic
solution, the absence of Mg2+ accelerated RVD and increased
cell permeabilization and IL-1b release (Figures 5E–5G). Due to
the lack of selective antagonists, TRPV2 involvement was
studied after silencing in THP-1 using small hairpin RNA (shRNA)
(Figures S4L and S4M). TRPV2 gene silencing decreased the
dye uptake and the release of IL-1b in response to hypotonic
treatment (Figures 5H and 5I) without affecting the RVD (Fig-
ure S4N). As previously described (Nagasawa et al., 2007), we
found that macrophage TRPV2 channels were localized on
intracellular endosomes (Figure 5J) and were translocated to
the plasma membrane after hypotonic stimulation (Figure 5K).
TRP Activation Modulates Intracellular Ca2+
and TAK1 Phosphorylation
TRP are cationic channels permeable to Ca2+. BAPTA-AM treat-
ment of THP-1 cells completely abolished the processing and
release of IL-1b in response to hypotonicity (Figure 6A), and
intracellular Ca2+ variation during cell volume regulation was492 Immunity 37, 487–500, September 21, 2012 ª2012 Elsevier Inc.sensitive to 2-APB (Figure 6B). It has been shown thatmembrane
stretch and intracellular Ca2+ activate TAK1 and that this kinase
plays a role in NLRP3 inflammasome activation (Fukuno et al.,
2011; Gong et al., 2010). We found that a decrease in extracel-
lular osmolarity induced phosphorylation of TAK1 (Figure 6C),
which is required for TAK1 activation (Sakurai et al., 2000).
Specific inhibition of TAK1 phosphorylation with the use of
5Z-7-oxozeaenol blocked hypotonicity-induced caspase-1
activation and IL-1b processing in a dose-dependent manner
(Figure 6C) without affecting intracellular K+ depletion (Figure 6D)
or the RVD (Figure 6E). Activation of TAK1 was abolished in the
presence of BAPTA-AM (Figure 6C) or when RVD was blocked
using NPPB (Figure 6F). Meanwhile, TRP channel inhibitor
2-APB blocked TAK1 phosphorylation (Figure 6G). IL-1b release
induced by hypotonicity was also highly reduced in cells wherein
the TAK1 gene was silenced (Figure 6H). Altogether, these
results show that during hypotonic stimulation, TAK1 plays
a key signaling role downstream of TRP channels in the activa-
tion of the NLRP3 inflammasome.
Hypertonic Solutions and TRP Inhibition Prevent
the Activation of the Inflammasome
Because a decrease in extracellular osmolarity induced NLRP3
activation, we next determined whether cell volume regulation
Immunity
Cell Swelling Activates Caspase-1might be a general mechanism for controlling the NLRP3 inflam-
masome. Using an in vivo model of ear inflammation dependent
on NLRP3 inflammasome activation (Sutterwala et al., 2006;Wa-
tanabe et al., 2007) (Figures 7A and 7B), we found that the size of
macrophages was enlarged within the inflamed tissue (Figures
7C and 7D). The in vivo use of 2-APB decreased both ear inflam-
mation and macrophage size (Figures 7A–7D), suggesting the
importance of macrophage size and TRP function during inflam-
mation as a feature of cell activation. Also, treatment of macro-
phages in vitro with 2-APB or La3+ blocked IL-1b release induced
by classical NLRP3 inflammasome activators, such as nigericin,
Escherichia coli, or MSU crystals (Figure 7E). Such treatments
did not affect IL-1b release induced by DNA-mediated AIM2 in-
flammasome activation (Figure 7E).
As expected, increasing media osmolarity in vitro with NaCl,
mannitol, or sorbitol inhibited hypotonicity-induced IL-1b release
(Figures 7F and 7G). We also found that hypertonic solutions
suppressed NLRP3 inflammasome-dependent IL-1b release
induced by nigericin, E. coli, Alu, and MSU crystals (Figures 7F
and 7G), without affecting AIM2 inflammasome activation (Fig-
ure 7G). Hypertonic solutions did not alter K+ efflux after nigericin
treatment (Figure S5B), suggesting that such solutions do not
work by affecting K+ efflux. However, cell swelling and RVD
were not common features of inflammasome activation; for
example, nigericin treatment induced a decrease in intracellular
K+ concentration and cell shrinking without affecting intracellular
Cl concentration (Figures S5A and S5C). Macrophages were
viable in iso-, hypo-, and hypertonic solutions, and gene ex-
pression for NLRP3, ASC, and caspase-1 was not affected by
these treatments (Figures S5D and S5E).
We wanted to confirm the in vivo relevance of this finding and
determine the molecular bases for the current use of hypertonic
solutions in clinics during brain inflammation (Jain, 2008). We
first found that a hypotonic solution activated caspase-1 in
mouse hippocampal neurons in culture (Figure 7H), confirming
previous data on functional neuronal caspase-1 (de Rivero Vac-
cari et al., 2008). As a proof of concept, we used a rat brain-injury
model induced by injection of kainic acid into the hippocampus
to induce cell swelling in vivo (Oprica et al., 2003). Microdialysis
perfusion of kainic acid in the hippocampus mainly activated
caspase-1 in the neurons of the pyramidal layer and dentate
gyrus (Figure 7I) and promoted the release of IL-1b (Figure 7J).
Both effects, caspase-1 activation and IL-1b release, were
reduced by perfusing a 20% sorbitol hypertonic solution after
the administration of kainic acid (Figures 7I and 7J).
Altogether, our data identify cell volume regulation as a basic
conserved homeostatic mechanism associated with the for-
mation and stimulation of the NLRP3 inflammasome via TRP
channels sensing cell swelling and controlling TAK1 activation.
DISCUSSION
In this study, we found that, among vertebrates, macrophage
swelling induced by hypotonic solutions is a conserved danger
signal for activating the NLRP3 inflammasome. This process
was dependent on the decrease of intracellular K+ and Cl and
a correct RVD process controlled by TRP channels. However,
it acted independently of P2X7 receptor signaling and cathepsin
B. As already described for other NLRP3 activators, K+ depletionImwas a necessary step to induce the activation of the inflamma-
some. Nevertheless, our study points out that this ionic depletion
is not sufficient to induce caspase-1 activation after hypotonicity
or nigericin treatment. We also provided molecular mechanistic
insights into the assembly and activation of the NLRP3 inflam-
masome in real time. Finally, our data showed that an increase
in extracellular osmolarity abrogated, in vivo, caspase-1 activa-
tion induced by cell swelling in immune (macrophages) and
nonimmune (neurons) cells.
Cell volume regulation is an ancient protection mechanism
for a change in extracellular osmolarity. During evolution, this
cellular response has been adapted as a signaling pathway
involved in many pathophysiological processes (Hoffmann
et al., 2009). We found that low osmolarity solutions and cell
swelling induced the recruitment of macrophages in vivo and
could be considered as a potential danger signal recognized
by the immune system. In fact, cell swelling was strongly associ-
ated with the activation of macrophages within the inflamed
tissue, with caspase-1 activation, and with the release of IL-1b
and IL-18 through the NLRP3 inflammasome. Lower vertebrates
and invertebrates present an expanded family of NLR receptors
(Hansen et al., 2011), but their function in controlling innate
immunity is not well understood, given that in fish and other lower
vertebrates, IL-1b sequence lacks a clear caspase-1 processing
site (Lo´pez-Castejo´n et al., 2008; Pelegrı´n et al., 2004). In
measuring caspase-1 activation, we found that contrary to
ATP, nigericin, MSU crystals, or Alu, a hypotonic solution was
able to activate caspase-1 in both mammalian and fish macro-
phages. This result identifies hypotonic environments as an
evolutionary alert mechanism conserved from fish tomammalian
macrophages for activating caspase-1.
The present model for NLRP3 inflammasome activation is
that upon activation, NLRP3 proteins oligomerize and thereby
interact with ASC to form a functional multiprotein complex
that activates caspase-1 (Jha and Ting, 2009; Schroder and
Tschopp, 2010). We used the BRET technique to study inflam-
masome protein dynamics in real time. Before any stimulation,
NLRP3 proteins formed a preassembled complex, as already
described for the NLRP1 inflammasome (Faustin et al., 2007).
In this complex, the pyrin domain of one NLRP3 was in close
proximity to the LRR domain of an adjacent NLRP3. Self-oligo-
merization of NLRP3 seems to be mediated by interaction of
the NACHT domains, in that the BRET signal and coIP were
impaired for NACHT-deleted NLRP3 constructs. ASC was able
to interact through the pyrin domain and compact preassembled
NLRP3 resting complexes, similar to what happened during in-
flammasome activation.
The NLRP3 inflammasome senses a wide range of danger
signals, including extracellular ATP or MSU crystals (Mariatha-
san et al., 2006; Martinon et al., 2006); however, there is no clear
common mechanism of NLRP3 activation. Our results demon-
strate that a common step is probably membrane stretch, which
induces activation of channels (like TRPV2 or pannexin-1) that
permeabilize cell membranes (Pelegrı´n and Surprenant, 2006,
2007). All known activators of the NLRP3 inflammasome induce
cell volume changes (swelling or shrinking) (Dise et al., 1980;
Schorn et al., 2011; Taylor et al., 2008), and the NLRP3 inflam-
masome could be a sensor of cellular membrane integrity.
Upon hypotonic cell swelling, the decrease in intracellularmunity 37, 487–500, September 21, 2012 ª2012 Elsevier Inc. 493
Figure 5. TRP Channels Control Caspase-1 Activation During RVD
(A) Kinetics of Yo-Pro uptake in THP-1 cells during hypotonicity in the absence or presence of LaCl3 (La, 2 mM), 2-APB (100 mM), ruthenium red (RR, 100 mM),
or GdCl3 (Gd, 2 mM); average traces of three independent experiments. r.f.u., relative fluorescence units.
(B) Relative intracellular K+ concentration of THP-1 cells treated as described in (A); n = 3 independent experiments.
(C) Western blot analysis of the cleavage of pro-IL-1b to its active p17 form (IL-1b) and of caspase-1 to its active p10 subunit by THP-1 cells treated as described
in (A). C, cell lysates; SN, supernatants.
(D) qRT-PCR of TRP channel family expression in THP-1 cells, human peritoneal macrophages (hPer), and blood monocytes (HPBM).
(E) Relative cell area of THP-1 cells in 90 mOsm solution with different concentrations of Mg2+. a.u., arbitrary units.
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Cell Swelling Activates Caspase-1K+ concentration carried by activation of mechanosensitive
potassium channels favored a conformational change in
NLRP3 proteins by generating the appropriate intracellular envi-
ronment for inflammasome activation, probably by increasing
electrostatic interactions between NLRP3 proteins as already
proposed (Zhang et al., 2011). However, our results rule out intra-
cellular K+ depletion as the unique cause of caspase-1 activa-
tion, because blocking RVD with Cl or TRP channel inhibitors
abolished the release of mature IL-1b without altering cellular
K+ depletion. Moreover, this conclusion was extended to other
NLRP3 activators, because IL-1b release induced by nigericin
was completely blocked by hypertonic solution without affecting
K+ efflux. Both K+ and Cl depletion activated RVD in macro-
phages as a protection mechanism for elevated membrane
tension. Therefore, extracellular osmolarity was sensed by
macrophages as a danger signal due to the increase in cellular
membrane tension during cell swelling, rather than only a deple-
tion of intracellular K+ or a direct detection of a change in extra-
cellular ionic strength. Indeed, swelling induced by glycerol in
a sodium solution of normal extracellular ionic strength still
induced caspase-1 activation. RVD is controlled by the activa-
tion of different membrane channels, including TRPM7 (Numata
et al., 2007). We found that, following cell swelling, a TRP
channel with a pharmacology profile similar to TRPM7 (sensitive
to ruthenium red, lanthanum, gadolinium, 2-APB, and magne-
sium concentration) regulated RVD in macrophages. After
maximum stretch during cell swelling, endomembranes derived
from endosomes and lysosomes are used to repair plasma
membrane damages (Togo et al., 2000). In macrophages, we
observed that this endomembrane fusion during RVD induced
TRPV2 trafficking to the cell surface. As already described for
large organic cations, TRPV2 activation is responsible for
membrane permeabilization to large molecules (Banke et al.,
2010). General blockers of TRP channels abolished RVD (prob-
ably controlled by TRPM7), cell permeabilization (due to
TRPV2), and caspase-1 activation without altering intracellular
K+ depletion. Cell permeabilization during swelling is also related
to the release of cytosolic ATP (Boudreault and Grygorczyk,
2004), which prompts autocrine and/or paracrine purinergic
P2X7 receptor signaling and NLRP3 inflammasome activation
(Babelova et al., 2009; Iyer et al., 2009; Sanz et al., 2009; Weber
et al., 2010). Also, P2X7-induced IL-1b release has been attrib-
uted to cell swelling (Perregaux et al., 1996). However, under
hypotonic conditions, swelling-induced ATP release and P2X7
receptor stimulation were not involved in the activation of(F) Kinetics of Yo-Pro uptake in THP-1 cells during hypotonic solution stimulatio
experiments.
(G) ELISA of IL-1b released by THP-1 cells primed with LPS (1 mg/ml, 4 hr) and sub
concentrations of Mg2+; n = 6 independent experiments.
(H) Kinetics of Yo-Pro uptake in THP-1 cells infected with GFP-lentivirus (GF
stimulation; average traces of three independent experiments.
(I) Western blot analysis of b-actin and of the cleavage of pro-IL-1b to its active
SN, supernatants.
(J) High-resolution, deconvolved images of TRPV2 and EEA1 immunostaining on
(K) TRPV2-myc or P2X2-myc plasma membrane biotinylation (top panels), total c
panels) on HEK293 cells treated for 40 min with iso- or hypotonic solution. Sca
strept., streptavidin-HRP.
Data are presented as mean ± SEM. *p < 0.05; **p < 0.005. See also Figure S4.
ImNLRP3. Our data show that TRP channel activation modulates
intracellular Ca2+ during cell volume regulation, and this change
in intracellular calcium appears to be crucial for the activation
of TAK1. A recent study has revealed that TAK1 plays a key role
in NLRP3 inflammasome activation (Gong et al., 2010) and that
TAK1 might be activated by intracellular Ca2+ variations
after membrane stretch (Fukuno et al., 2011). We found that,
following hypotonic stimulation, TAK1 activation was regulated
by TRP activity during RVD and was required for caspase-1
activation and IL-1bprocessing.Wealso found that TRPblockers
were effective in inhibiting MSU crystal- and nigericin-induced
caspase-1 activation, but the specific involvement of TRP chan-
nels, particularly of TRPV2, in NLRP3 activation will have to be
confirmedby genetic ablation inmousemodels (Link et al., 2010).
Hypertonic solutions are used in clinics to reduce brain edema
and to reconstitute fluids in patients with trauma or severe sepsis
(Jain, 2008; Oliveira et al., 2002). We found that macrophages
at inflamed tissues present a characteristic morphology with
a considerable increase in cellular volume, sensitive to TRP
blockers. In vitro, hypertonic solutions were able to inhibit the
NLRP3 inflammasome in response to different stimuli without
affecting IL-1b release induced by AIM2 activation. These results
suggest that cellular volume changes specifically modulate
activation of the NLRP3 inflammasome toward other inflamma-
tory supramolecular complexes. Although the different NLRP3
stimuli do not directly cause cell swelling (Dise et al., 1980; Taylor
et al., 2008), the potential benefit of inhibiting inflammasome
activation by inducing cell shrinking using hypertonic solution
reinforces the current clinical use of hypertonic osmotherapy to
treat different inflammatory diseases (Jain, 2008; Oliveira et al.,
2002). To date, the beneficial anti-inflammatory effects of hyper-
tonic solutions have mainly been attributed to instantaneous
hemodynamic redistribution of interstitial and cellular water
into the circulation by the osmotic gradient produced (Diringer
and Zazulia, 2004; Oliveira et al., 2002). However, their use
for reducing inflammation is highly debated, given that no
clear molecular mechanism has been attributed to their action.
We found that, in vivo, kainic acid administration activates
caspase-1 in neurons and IL-1b release. Perfusion of a hyper-
tonic solution reduced both effects and demonstrates that
neuronal cell swelling in vivo is also coupled with caspase-1
activation. Although NLRP1 has been proposed as the neuronal
inflammasome platform (de Rivero Vaccari et al., 2008), it needs
to be confirmed whether in vivo kainic acid activates the NLRP3
or NLRP1 inflammasome in neurons. These data supportn with different concentrations of Mg2+; average traces of three independent
sequently subjected to different extracellular osmolarities for 1 hr with different
P-Lv) or with shTRPV2-lentivirus (TRPV2-shRNA) during hypotonic solution
p17 form (IL-1b) by THP-1 cells infected as described in (H). C, cell lysates;
mouse peritoneal macrophages; scale bar represents 2.5 mm.
ell lysate immunoblot (middle panels), or TRPV2-myc immunostaining (bottom
le bar represents 2.5 mm; arrowhead denotes TRPV2 membrane localization.
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Figure 6. TRP Channels Modulate Macrophage Intracellular Ca2+ and TAK1 Activation
(A) Western blot analysis of the cleavage of pro-IL-1b to its active p17 form (IL-1b) by THP-1 cells primed with LPS (1 mg/ml, 4 hr) and subsequently subjected to
300 or 90 mOsm extracellular solution for 1 hr, in the presence or absence of BAPTA-AM (100 mM).
(B) Intracellular Ca2+ changes of THP-1 cells treated as in (A) in the presence or absence of 2-APB (100 mM), BAPTA-AM (100 mM), or an extracellular buffer without
calcium (EGTA).
(C) Western blot analysis of TAK1 phosphorylation and the cleavage of pro-IL-1b to its active p17 form (IL-1b) and of caspase-1 to its active p10 subunit by THP-1
cells treated as in (A), in the presence or absence of different concentrations of 5Z-7-oxozeaenol (OXO) or BAPTA-AM (100 mM).
(D) Relative intracellular K+ concentration of THP-1 cells primed as in (C); n = 3 independent experiments.
(E) Relative cell area of THP-1 cells treated as in (C). n = 50 cells per condition. a.u., arbitrary units.
(F and G) Western blot analysis of TAK1 phosphorylation and the cleavage of pro-IL-1b to its active p17 form (IL-1b) by THP-1 cells treated as in (A), in the
presence or absence of NPPB (100 mM) (F), or 2-APB (100 mM) (G).
(H) Western blot analysis of TAK1 phosphorylation, b-actin, and the cleavage of pro-IL-1b to its active p17 form (IL-1b) by THP-1 cells silenced or not for the TAK1
gene, following hypotonic stimulation.
Data are presented as mean ± SEM.
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Figure 7. Inflammation Is Blocked by TRP Inhibition or Hypertonic Solutions
(A) Representative histology of mouse ear inflammatory model induced with allyl isothiocyanate (AITC) in the presence of absence of 2-APB (100 mM); repre-
sentative of five different animals; scale bar represents 40 mm.
(B) Measurements of ear inflammation (n = 25 sections per condition).
(C) Measurements of F4/80 positive macrophage size inside the inflamed ear tissue (n = 30–60 macrophages per condition).
(D) Representative histology of mouse ear macrophage; scale bar represents 20 mm.
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Cell Swelling Activates Caspase-1previous studies indicating that the activation of caspase-1
could contribute to the proinflammatory effects associated
with different brain pathologies, such as epilepsy or stroke,
wherein neuronal swelling has been reported (de Rivero Vaccari
et al., 2008; Rothwell, 2003; Simard et al., 2007).
Altogether, these results reveal that drugs targeting TRP chan-
nels or the signaling pathway of cell volume regulatory process
are promising tools for reduction of inflammation, as well as for
treatment of pathologies linked to caspase-1 and NLRP3 activa-
tion. Therefore, we propose cell swelling as an evolutionarily
conserved homeostatic mechanism associated with the forma-
tion of the NLRP3 inflammasome.
EXPERIMENTAL PROCEDURES
Animals
MaleC57BL/6mice (6–8weeks old) were obtained fromHarlan andmaintained
in specific pathogen-free conditions. Healthy specimens (150 g) of the marine
fish gilt-head sea bream (Sparus aurata, Actinopterygii, Sparidae) were main-
tained in 14 m3 running seawater aquaria. The local ethical committees from
University Hospital Virgen de la Arrixaca, University of Murcia, and Hospital
Ramo´n y Cajal approved all animal experiments. P2rx7-deficient mice (Ches-
sell et al., 2005) were from the laboratory of A. Verkhratsky, and bone marrow
from Casp1- (Kuida et al., 1995), Nlrp3- (Martinon et al., 2006), and Pycard-
(Mariathasan et al., 2004) deficient mice were a generous gift of I. Coullin.
Intraperitoneal Administration of Hypotonic Solution
Mice were treated with daily i.p. injections of 100 ml/kg1 of iso- or hypotonic
solution for 4 consecutive days. Three hours after the last injection, animals
were sacrificed, and peritoneal cavities were washed. The lavage was
analyzed for macrophage size and presence by flow cytometry using F4/80-
AlexaFluor488 antibody (Caltag) on a FACScalibur (BD Biosciences). The
macrophage population was analyzed using WinList software (Verity Software
House).
Kainic Acid Brain Injury Model
Brain microdialysis of kainic acid in adult Sprague-Dawley rats aged 10–
12 weeks was already described (Hsu et al., 2007; Oprica et al., 2003). In
brief, each hippocampus was stereotaxically (anterior-posterior: 4.6 mm;
lateral: ± 2.6 mm from bregma; ventral: 2.6 mm from dura) implanted with
a CMA/12 microdialysis probe (CMA Microdialysis); after 2 hr washout,
100 mM kainic acid was perfused for 1 hr (flow: 1 ml/min), followed by the infu-
sion of isotonic Krebs-Ringer bicarbonate (KRB) solution (280–290 mOsm) in
one hippocampus and hypertonic KRB supplemented with 20% sorbitol
(1400–1500 mOsm) in the contralateral side. Samples for IL-1b analysis were
collected every hour for 8 hr. At the end of the experiment, the biotinylated
caspase-1 inhibitor (100 mm biotinyl-YVAD-CMK, AnaSpec) was perfused
for 1 hr. After 12 hr, animals were sacrificed, and brains were removed for
immunohistochemical studies.
Cells, Treatments, and Procedures
Mouse primary bone marrow-derived macrophages (BMDM), peritoneal
macrophages, immortalized mouse BMDM, fish macrophages, and THP-1(E–G) IL-1b release detected by ELISA (E and G) or western blot (F) in THP-1 cells p
Hypos. or Hyposmotic), nigericin (25 mM,Nig), Alu (500mg/ml), MSU (500mg/ml),
buffer was supplemented with 2-APB (100 mM), LaCl3 (La, 2 mM), NaCl (150 mM
(H) Representative images of hippocampal mouse neurons in culture, treated wit
caspase-1 (FLICA, green), MAP2 (red), and DAPI. Scale bars represent 20 mm (le
(I) Histochemical detection of active caspase-1 in the rat hippocampus after adm
bicarbonate solution supplementedwith 20%of sorbitol). Active caspase-1 (green
and the dentate gyrus (GD). Scale bar represents 100 mm.
(J) ELISA of IL-1b release in the hippocampus of rats after administration of 100 mM
treatment.
Data are presented as mean ± SEM. ***p < 0.001; **p < 0.005; *p < 0.05. See als
498 Immunity 37, 487–500, September 21, 2012 ª2012 Elsevier Inc.and HEK293 cell cultures were described previously (Hornung et al., 2008;
Lo´pez-Castejo´n et al., 2008; Lopez-Castejon et al., 2010; Pelegrı´n and
Surprenant, 2009). For details of hippocampal cultures, human macrophage
isolation, and BRET measurements, see Supplemental Information. If not
specified, all macrophages were primed for 4 hr with LPS (1 mg/ml) previous
to hypotonic-solution challenge. For TRPV2 gene silencing, THP-1 cells
were infected with recombinant lentivirus vectors, and experiments were
performed 7 days after infection. For TAK1 gene silencing, THP-1 cells were
cultured in the presence of an Accell TAK1 small interfering RNA (siRNA) or
Accell nontargeting siRNA pool (Thermo Scientific Dharmacon) for 72 hr
according to manufacturer’s instruction. If not mentioned in the text, all the
hypo- and isotonic solutions had an osmolarity of 90 and 300 mOsm, respec-
tively. The 90 mOsm hypotonic solution was achieved by diluting isotonic
physiology electrophysiology-total buffer (Pelegrı´n and Surprenant, 2009)
1:4 with distilled sterile water.
Detailed methods for quantitative RT-PCR (qRT-PCR), RT-PCR, immunocy-
tochemistry, microscopy, western blots, coIP, IP, lactate dehydrogenase
measurements, ELISA, cathepsin release, dye uptake, plasma membrane
biotynilation, and FLICA (fluorescent labeled inhibitor of caspases) staining
have been previously described (Lo´pez-Castejo´n et al., 2008; Lopez-Castejon
et al., 2010; Pelegrı´n and Surprenant, 2009). Intracellular K+ concentration was
analyzed on a Hitachi-917 (Roche). Macrophage area measurements were
quantified from >50 cells per condition per time point using National Institutes
of Health (NIH) ImageJ software (http://rsb.info.nih.gov/ij). The University
Hospital Virgen de la Arrixaca clinical ethics committee approved the collec-
tion of human samples, upon patient consent, for purifying human peritoneal
macrophages and peripheral blood monocytes.
Statistical Analysis
All data are shown as mean values, and error bars represent SEM from the
number of assays indicated (from at least three independent experiments).
For statistical comparisons, data were analyzed by an unpaired two-tailed
Student’s t test to determine differences between groups using Prism software
(GraphPad Software); the p value is indicated in the figure legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.immuni.2012.06.013.
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